Claude Maraoui
Fortuna: 15 M $ al 31/05/2026
Fortuna: 15 M $ al 31/05/2026
Mr. Claude Maraoui is a President, Chief Executive Officer & Director at Journey Medical Corp.
and a Member at American Academy of Dermatology.
He is on the Board of Directors at Journey Medical Corp.
Mr. Maraoui was previously employed as a Vice President-Dermatology Sales by Medicis Pharmaceutical Corp.
He received his undergraduate degree from Rutgers State University of New Jersey.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
JOURNEY MEDICAL CORP. 11,31 % | 22/04/2026 | 2.435.990 ( 11,31 % ) | 15 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JOURNEY MEDICAL CORPORATION | Fundador | 01/10/2014 |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| MEDICIS PHARMACEUTICAL CORP | Corporate Officer/Principal | 01/04/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services Operates as dermatologists organizations | Commercial Services |
Journey Medical Corp.
Journey Medical Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for the treatment of dermatological treatment conditions | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.